Evidence map›Paper›PMID 37716510›Full record

ArticleMucosal immunology2023

Fundamental role for the creatine kinase pathway in protection from murine colitis.

Caroline H T Hall, Jordi M Lanis, Alexander S Dowdell, Emily M Murphy, Geetha Bhagavatula, Rane M Neuhart, Kiranmayee Yenugudhati Vijaya Sai, Sean P Colgan

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Mucosal Responses to Type II Interferon in IBD.Inflammatory bowel diseases · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Caroline H T HallDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado and University of Colorado, Aurora, Colorado, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA.
Jordi M LanisDivision of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA; Department of Immunology and Microbiology, University of Colorado, Aurora, Colorado, USA.
Alexander S DowdellDivision of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA; Rocky Mountain Veterans Hospital, Aurora, Colorado, USA.
Emily M MurphyDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado and University of Colorado, Aurora, Colorado, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA.
Geetha BhagavatulaDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado and University of Colorado, Aurora, Colorado, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA.
Rane M NeuhartDivision of Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado and University of Colorado, Aurora, Colorado, USA; Division of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA.
Kiranmayee Yenugudhati Vijaya SaiDivision of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA; Rocky Mountain Veterans Hospital, Aurora, Colorado, USA.
Sean P ColganDivision of Gastroenterology and Hepatology, Department of Medicine, Mucosal Inflammation Program and University of Colorado, Aurora, Colorado, USA; Rocky Mountain Veterans Hospital, Aurora, Colorado, USA. Electronic address: sean.colgan@CUAnschutz.edu.
Children's Hospital Colorado · USUniversity of Colorado Hospital · USUniversity of Colorado Anschutz Medical Campus · US

Funding

ROLE OF EPITHELIA IN ISCHEMIA/REPERFUSION INJURYR01DK050189 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI COLGAN, SEAN P · 2000 to 2024
$5.0M
Mechanisms of Adenosine ProtectionR01DK095491 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Sean P Colgan · 2012 to 2026
$4.9M
Metabolic Regulation of Inflammation by Microbial SCFAR01DK104713 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Sean P Colgan · 2015 to 2026
$4.7M
Institutional Career Development CoreKL2TR002534 · NCATS · UNIVERSITY OF COLORADO DENVER · PI BURNHAM, ELLEN L · 2018 to 2022
$4.6M
Hypoxia, HIF, and Mucosal InflammationR37DK050189 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI COLGAN, SEAN P · 2010 to 2019
$4.1M
METABOLIC CONTROL OF EPITHELIAL AUTOPHAGY DURING INFLAMMATIONR01DK103712 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI COLGAN, SEAN P · 2015 to 2019
$1.7M
Microbiota-sourced purines in gut health and diseaseK01DK129410 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LEE, JOSEPH SCOTT · 2021 to 2025
$739k
HIF-Regulated Autophagy in Host-microbe InteractionsIK2BX006088 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI ALEXANDER Shea DOWDELL · 2024 to 2026
–
EPITHELIA AND ISCHEMIA/REPERFUSION INJURYR29DK050189 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI COLGAN, SEAN P · 1995 to 1999
–
Metabolic Regulation of Mucosal InflammationI01BX002182 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI COLGAN, SEAN P · 2014 to 2025
–
BLRD VA I01 BX002182BLRD VA IK2 BX006088BLRD VA IK6 BX006475NCATS NIH HHS KL2 TR002534NIDDK NIH HHS K01 DK129410NIDDK NIH HHS R01 DK050189NIDDK NIH HHS R01 DK095491NIDDK NIH HHS R01 DK103712NIDDK NIH HHS R01 DK104713NIDDK NIH HHS R29 DK050189NIDDK NIH HHS R37 DK050189
6 · The paper itself

Abstract

Inflammatory diseases of the digestive tract, including inflammatory bowel disease, cause metabolic stress within mucosal tissue. Creatine is a key energetic regulator. We previously reported a loss of creatine kinases (CKs) and the creatine transporter expression in inflammatory bowel disease patient intestinal biopsy samples and that creatine supplementation was protective in a dextran sulfate sodium (DSS) colitis mouse model. In the present studies, we evaluated the role of CK loss in active inflammation using the DSS colitis model. Mice lacking expression of CK brain type/CK mitochondrial form (CKdKO) showed increased susceptibility to DSS colitis (weight loss, disease activity, permeability, colon length, and histology). In a broad cytokine profiling, CKdKO mice expressed near absent interferon gamma (IFN-γ) levels. We identified losses in IFN-γ production from CD4

Indexed as

ColitisInflammatory Bowel DiseasesAnimalsCD8-Positive T-LymphocytesColonCreatineCreatine KinaseCytokinesDextran SulfateDisease Models, AnimalHumansHypoxiaInflammationInterferon-gammaMiceMice, Inbred C57BLCreatineCreatine KinaseCytokinesDextran SulfateInterferon-gamma

Identifiers

PMID37716510
PMCPMC12070598
OpenAlexW4386779576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.